Bio
Jeremy Wolk is a partner in the firm’s Corporate Practice Team, bringing more than 25 years of experience guiding companies through complex corporate, strategic, and intellectual property transactions. With a background spanning both outside counsel and in-house general counsel roles, he offers a balanced, business-focused perspective that blends sophisticated insight with practical execution.
Jeremy advises on mergers and acquisitions, private equity, venture capital transactions, independent sponsor deals, joint ventures and strategic alliances, enterprise-level commercial arrangements, and a broad range of intellectual property–driven transactions. When acting as an outside general counsel, he delivers practical, business-aligned guidance on corporate governance, commercial operations, and the transactions that support them, serving clients from emerging companies without in-house legal teams to large organizations with fully developed legal departments. His experience leading buy-side, sell-side, and strategic initiatives enables him to navigate complex transactions across industries, helping clients protect value, drive growth and achieve strategic objectives.
Clients value Jeremy’s ability to “speak Geek” and bridge the gap between business leaders, technology teams, and legal concepts. He regularly structures agreements that protect enterprise value, enable data-driven initiatives, and create opportunities to monetize intellectual property. He has extensive experience in negotiating inbound and outbound licensing, information technology, and cloud “as-a-service” agreements, outsourcing initiatives, brand promotion programs, and data transfer and cybersecurity matters, as well as a broad suite of other IP and technology transactions that support innovation, operational transformation, and revenue growth.
Before joining Lippes, Jeremy spent more than a decade as a partner at Nixon Peabody LLP. Earlier in his career, he served as Senior Vice President, Deputy General Counsel, and Corporate Secretary of iVillage Inc., a NASDAQ-listed public company acquired by NBCUniversal for $600 million. During his seven years as general counsel, he advised on corporate, securities, and strategic transactions across the company’s online, print, television, and consumer products businesses. This experiences gives him a deep understanding of organizational demands, the pressures on the C-Suite and in-house legal teams, and the practical considerations that shape business decisions.
Known for his judgment, responsiveness, and solutions-oriented style, Jeremy helps clients seize opportunities, manage risk, and achieve desired results at the intersection of law and business.
Representative Matters
- Directed Hickey Freeman Tailored Clothing and its affiliates through company sale processes, including to Tom James Company. Negotiated multiple brand licensing agreements with Authentic Brands Group, aligning the luxury tailored clothing manufacturer with the strategy of the world’s largest brand aggregator
- Represented global information technology solutions and services company in acquisition of assets from major entertainment company and related transactional matters involving conversion of application suite to software-as-a-service offering to major movie and television studios
- Advised Valaquenta Intellectual Properties Limited, a Bermuda company, in several intellectual property transactions, including the sale of assets and patent licenses of foreign exchange trading platform to Gain Capital Holdings, Inc. (GCAP).
- Served as intellectual property and information technology subject matter expert on a leading human capital management and payroll solutions provider’s acquisition of an AI-driven legal advisory and automation platform from a law firm. Ensured protection of IP rights, compliance with data privacy laws, and seamless integration of technology, including challenging IP license-back negotiations, use restrictions, and non-competition agreements.
- Advised on Obagi Medical’s $1.2B SPAC merger with a publicly traded acquisition company, including structuring multifaceted licensing and manufacturing arrangements arising from the bifurcation of commercialization rights by country to support global operations, protect IP, and uphold quality control standards.
- Managed commercial contracts as outsourced general counsel, including agreements for technology development, implementation, and maintenance, as well as supply, distribution, services, and supplier arrangements for academic institutions and companies across diverse industries.
- Negotiated agreements for the strategic initiatives of both a Fortune 500 beer, wine, and spirits producer and a leading online grocery delivery company to procure and implement warehouse management software, robotics, and automated fulfillment systems – modernizing enterprise platforms, transforming operations, and significantly enhancing distribution efficiency.
- Secured licensing rights for a Fortune 500 beer, wine, and spirits producer to develop and distribute alcoholic beverages under a leading global beverage brand, structuring terms that balanced brand protection with operational autonomy and addressing complex cross-border manufacturing, regulatory, and marketing requirements.
- Facilitated large-scale software implementations for major health systems, deploying critical EHR and ePrescribing platforms such as Oracle Health (Cerner) and EPIC, and leading negotiations for licensing, IT consulting, data sharing collaborations, and software development agreements.
- Served as the subject matter expert on intellectual property, information technology, and privacy matters for a private equity investment in Bombas socks, guiding risk mitigation and regulatory disclosures in the wake of a historical privacy breach.
- Structured private equity, venture capital, and exempt securities offerings, including a $55M private placement of stock and warrants for a real estate investment trust and its asset manager.
- Represented Bermuda IP holding company in acquiring patent assets from Intellectual Venutres, a global leader in invention capital and patent licensing with an extensive portfolio of technological assets.
